NEU neuren pharmaceuticals limited

Ann: 2022 Annual Report to shareholders, page-4

  1. 1,419 Posts.
    lightbulb Created with Sketch. 376
    a good report to remind us the further upside from here is much bigger:

    The transformation of Neuren is just beginning, and the board is committed to maximizing value for our shareholders by maintaining a robust balance sheet that can facilitate the pursuit of all value adding opportunities to their fullest potential
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.54
Change
-0.420(3.24%)
Mkt cap ! $1.574B
Open High Low Value Volume
$12.82 $13.05 $12.53 $4.896M 381.9K

Buyers (Bids)

No. Vol. Price($)
9 783 $12.53
 

Sellers (Offers)

Price($) Vol. No.
$12.55 814 17
View Market Depth
Last trade - 15.26pm 17/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.